Cargando…
Hypothesis: Possible influence of antivector immunity and SARS‐CoV‐2 variants on efficacy of ChAdOx1 nCoV‐19 vaccine
The present work provides arguments for the involvement of anti‐vector immunity and of SARS‐CoV‐2 variants on the efficacy of ChAdOx1 nCoV‐19 vaccine. First, it is suggested that anti‐vector immunity takes place as homologous vaccination with ChAdOx1 nCoV‐19 vaccine is applied and interferes with va...
Autores principales: | Zamai, Loris, Rocchi, Marco B. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444749/ https://www.ncbi.nlm.nih.gov/pubmed/34331459 http://dx.doi.org/10.1111/bph.15620 |
Ejemplares similares
-
Subclinical thrombotic thrombocytopenic purpura after vaccination with ChAdOx1 nCoV-19
por: Jang, Hee Ryeong, et al.
Publicado: (2021) -
ChAdOx1 nCoV-19 vaccine for SARS-CoV-2
por: Lodge, Archie
Publicado: (2020) -
ChAdOx1 nCoV-19 vaccine for SARS-CoV-2
por: Chauhan, Anil, et al.
Publicado: (2020) -
Depression following ChAdOx1-S/nCoV-19 vaccine
por: Uvais, N.A.
Publicado: (2022) -
Reversible radiculomyelitis after ChAdOx1 nCoV-19 vaccination
por: Spataro, Rossella, et al.
Publicado: (2022)